Avalyn Pharma Inc. Common Stock (AVLN) vs ORIC Pharmaceuticals, Inc. (ORIC)
A side-by-side comparison of Avalyn Pharma Inc. Common Stock and ORIC Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVLN
Avalyn Pharma Inc. Common Stock
$25.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ORIC
ORIC Pharmaceuticals, Inc.
$11.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AVLN vs ORIC
growth of $100 · dividends reinvested · last 1yAVLN -8.3% (-8.3%/yr)ORIC +32.3% (+32.3%/yr)ORIC compounded faster over this window
AVLN ORIC
AVLN vs ORIC: by the numbers
- •ORIC is the larger company ($1.24B vs $1.13B market cap).
Metrics side by side
Valuation
| Metric | AVLN | ORIC |
|---|---|---|
| P/B ratio | 2.83 | 3.25 |
Profitability
| Metric | AVLN | ORIC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -36.81% |
| ROIC | -67.73% | -40.32% |
Growth (annualized)
| Metric | AVLN | ORIC |
|---|---|---|
| Total return CAGR (5Y) | N/A | -8.73% |
Go deeper
Dig into the metrics
Avalyn Pharma Inc. Common Stock ROEORIC Pharmaceuticals ROEAvalyn Pharma Inc. Common Stock operating marginORIC Pharmaceuticals operating marginAvalyn Pharma Inc. Common Stock revenue growthORIC Pharmaceuticals revenue growthAvalyn Pharma Inc. Common Stock free cash flowORIC Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.